Fundz

Spruce Biosciences, Inc. reported raising $88 Million in an initial SEC Form D filing, from an offering of $88 Million

PUBLIC · SPRBFeb 28, 2020

Amount Raised

$88 Million

$88 Million sold, per SEC Form D (first sale Feb 28, 2020)

Round Type

Venture

South San FranciscoBiotechnology

Quick answer

Spruce Biosciences raised $88 Million in a funding round, dated February 28, 2020. Spruce Biosciences is based in South San Francisco, California, United States.

How much did Spruce Biosciences raise?
Spruce Biosciences raised $88 Million in a funding round on February 28, 2020.
What does Spruce Biosciences do?
Spruce Biosciences, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.
Where is Spruce Biosciences based and how big is it?
Spruce Biosciences is based in South San Francisco, California, United States. Fundz records about 20 employees.
Who are the decision-makers at Spruce Biosciences?
Fundz holds 2 contacts at Spruce Biosciences, including the Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Spruce Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Halo Labs raised $6.7M on April 13, 2020.
  • Stealth BioTherapeutics Corp raised $20M on April 13, 2020.
  • Embody raised $9.3M on April 10, 2020.
  • Crispr Therapeutics raised $1M (Seed) on April 9, 2020.
  • iTeos Therapeutics, Inc. raised $125M on April 9, 2020.
  • EternaTear, Inc. raised $2.2M (Seed) on April 9, 2020.

Who to call at Spruce Biosciences, and when

A new round usually means Spruce Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Spruce Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Spruce Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Spruce Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Spruce Biosciences

Location

611 Gateway Boulevard, Suite 740

South San Francisco, California, United States

About

Spruce Biosciences, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company aims to address significant unmet medical needs through innovative treatment solutions. Spruce has a particular focus on rare diseases and is committed to serving patient communities. They are known for their work in enzyme replacement therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Spruce Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsAlexis H., Founder hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Spruce Biosciences's next move

See what Strategic adds

Spruce Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.